Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.


Report: North American Robotics Market Surges 32 Percent in Unit Volume

Ann Arbor, MI, May 6, 2017 — North American robotics companies posted the strongest ever first-quarter results, according to the Robotic Industries Association (RIA), the industry’s trade group.  Both robot orders and shipments achieved record levels.

An all-time high total of 9,773 robots valued at approximately $516 million were ordered from North American robotics companies during the first quarter of 2017.  This represents growth of 32 percent in units over the same period in 2016, which held the previous record. Continue reading

Calling, Dr. Robot! A New Crop of Robots to Vie for Space in the Operating Room

Surgical RobotChicago, IL, July 28, 2016 ― Reuters reports that even though many doctors see need for improvement, surgical robots are poised for big gains in operating rooms around the world.

Within five years, one in three U.S. surgeries—more than double current levels—is expected to be performed with robotic systems, with surgeons sitting at computer consoles guiding mechanical arms.

Companies developing new robots also plan to expand their use in India, China and other emerging markets. Continue reading

Kessler Foundation and NJIT Secure $5M Grant to Study Wearable Robots

NJIT LogoNewark, NJ, January 18, 2016 ― A joint team from Kessler Foundation and the New Jersey Institute of Technology (NJIT) is developing new applications for wearable robotic exoskeleton devices with a $5 million federal grant from the National Institute on Disability, Independent Living and Rehabilitation Research.

Researchers from the two institutions are working together on the next generation of robotic exoskeletons to improve mobility and to enable safer, more independent functioning for people with spinal cord injuries (SCI), Duchenne Muscular Dystrophy and stroke. Continue reading